Oscar Health, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $11.7B | $9.2B | $5.9B | $4.0B | $1.8B |
| Operating income | -$396.4M | $57.3M | -$235.6M | -$589.9M | -$544.5M |
| Cash from operations | $1.1B | $978.2M | -$272.2M | $380.3M | -$181.7M |
| Capital expenditure | $36.4M | $27.9M | $25.6M | $29.0M | $25.9M |
| Free cash flow | $1.1B | $950.3M | -$297.7M | $351.3M | -$207.6M |
| Share repurchases | — | — | — | — | $0 |
| Total assets | $6.3B | $4.8B | $3.6B | $4.5B | $3.3B |
| Total liabilities | $5.3B | $3.8B | $2.8B | $3.6B | $1.9B |
Shares outstanding 301.5M · Free float 77.4%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.